NF-kB and the CLL microenvironment. (2023)
Attributed to:
Overcoming Ibrutinib and Venetoclax resistance in Chronic Lymphocytic Leukaemia.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fonc.2023.1169397
PubMed Identifier: 37064123
Publication URI: http://europepmc.org/abstract/MED/37064123
Type: Journal Article/Review
Volume: 13
Parent Publication: Frontiers in oncology
ISSN: 2234-943X